Skip to main content
OpenTrials

Clinical trial condition

Fabry Disease

Explore clinical trials studying Fabry Disease. Study availability and eligibility vary by location and protocol.

158 public trials 34 recruiting studies
Refine in advanced search Browse all conditions

Fabry Disease trial results

Completed

Open Label Extension of 2 mg/kg Pegunigalsidase Alfa (PRX-102) Every 4 Weeks in Adult Fabry Disease Patients

NCT03614234

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +29 more
Locations
  • UAB Medicine Birmingham, Alabama, United States
  • Emory University School of Medicine Atlanta, Georgia, United States
  • University of Iowa Hospitals and Clinica Iowa City, Iowa, United States
  • Infusion Associates Grand Rapids, Michigan, United States
View all 14 locations
View Trial Details
Completed

Dose-Ranging Study of ST-920, an AAV2/6 Human Alpha Galactosidase A Gene Therapy in Subjects With Fabry Disease (STAAR)

NCT04046224

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations
  • University of California, Irvine Irvine, California, United States
  • University of South Florida Tampa, Florida, United States
  • Emory University School of Medicine Atlanta, Georgia, United States
  • Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
View all 18 locations
View Trial Details
Completed

Open Label Extension Study of 1 mg/kg Pegunigalsidase Alfa Every 2 Weeks in Patients With Fabry Disease

NCT03566017

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +29 more
Locations
  • UAB Medicine Birmingham, Alabama, United States
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • University of California San Diego La Jolla, California, United States
  • University of California Irvine Center Orange, California, United States
View all 30 locations
View Trial Details
Completed

Early Detection of Fabry Disease

NCT05106764

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations
  • Universitätsklinikum Erlangen Kinder- und Jugendklinik Erlangen, Germany
  • Universitätsklinikum Erlangen Neurologische Klinik Erlangen, Germany
  • Universitätsklinikum Giessen Giessen, Germany
View Trial Details
Completed

Switch Over Study of Biosimilar Agalsidase Beta for Fabry Disease

NCT05843916

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations
  • Instituto de Nefrología Pergamino S.R.L Pergamino, Buenos Aires, Argentina
  • Centro Médico Santa María de la Salud San Isidro, Buenos Aires, Argentina
  • Instituto de Investigaciones Clínicas Quilmes Buenos Aires, Argentina
  • Clínica Universitaria Reina Fabiola Córdoba, Argentina
View Trial Details

Related conditions